Reference
Detournay B, et al. Treatment Costs of Basal Insulin Regimens for Type 2 Diabetes Mellitus in France. PharmacoEconomics-Open : 20 Nov 2020. Available from: URL: https://doi.org/10.1007/s41669-020-00237-4
Rights and permissions
About this article
Cite this article
New basal insulins in T2DM: cost not increased, hypoglycaemia reduced. Reactions Weekly 1832, 14 (2020). https://doi.org/10.1007/s40278-020-86547-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-86547-2